Application of topical corticosteroids to sites of positive immediate-type allergy skin tests to relieve itching: Results of a double-blind, placebo-controlled trial

Annals of Allergy, Asthma and Immunology

Volumn 98, Issue 2, 2007, Pages 182-184

  Kelso, John M ^a,b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; PLACEBO; UNCLASSIFIED DRUG; VANICREAM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEX; SKIN TEST; TREATMENT OUTCOME; TREATMENT RESPONSE; URTICARIA; VISUAL ANALOG SCALE;

EID: 33846844947     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60694-1     Document Type: Article

References (3)

1. Kaplan AP. Clinical practice: chronic urticaria and angioedema. N Engl J Med. 2002;346:175-179.
2. Lavker RM, Schechter NM, Guzzo C, Lazarus GS. Aggressive topical corticosteroid therapy: a novel approach to mast-cell-dependent cutaneous disorders. Dermatologica. 1987;175:213-216.
3. Lawlor F, Black AK, Murdoch RD, Greaves MW. Symptomatic dermographism: wealing, mast cells and histamine are decreased in the skin following long-term application of a potent topical corticosteroid. Br J Dermatol. 1989;121:629-634.